Researchers are increasingly studying “super responders,” those patients that respond well to a drug that does not work in most people. Academic centers, such as Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center and Dana-Farber Cancer Institute, are pursuing such studies in order to find genetic mutations that can be linked to a drug that […]
It has long been held that each person has one genome, meaning each of their cells share the same basic genetic material. Following decades of rare cases that disputed this, the tenet is now being upended by the discovery of a greater number of individuals with multiple genomes. Called chimerism, the condition is being discovered […]
The NIH has released its interim report on the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (see IBO 4/15/13). Prepared by an Advisory Committee to the Director working group, the report is based on consultations with the scientific community and public workshops. It identified six themes: appropriate experimental systems and models; cross boundaries in […]
Despite concerns over the US debt ceiling and a potential government shutdown, equity markets advanced in September due to the Federal Reserve’s decision to continue its bond purchase program, as well as improving economic data, including higher personal income and spending. However, consumer sentiment shifted more negatively in September as a result of discouraging prospects […]
Washington, DC 8/20/13; San Diego, CA 9/23/13—Sequenom has announced it is reviewing potential strategic alternatives for its Genetic Analysis business. In addition, last month, the company announced in an SEC filing a cost reduction effort that includes the termination of approximately 75 employees. The company expects to record $10 million in compensation-related expenses in future […]
Engham, UK 9/30/13; Amesbury, UK 9/30/13; Malvern, UK 9/30/13—Spectris’s Malvern Instruments business, which provides instrumentation for materials and biophysical characterization, has acquired NanoSight for £15 million ($24 million = £0.62 = $1) net of debt and cash acquired. NanoSight’s Nanoparticle Tracking Analysis technology enables the simultaneous multi-parameter analysis and characterization of different types of nanoscale […]
Menlo Park, CA 9/25/13; Washington DC 9/25/13—Sequencer maker Pacific Biosciences has announced an agreement with Roche Diagnostics to develop and manufacture diagnostic products, including sequencing systems and consumables. The products will be sold exclusively to Roche, which will distribute them in the human IVD field. Pacific Biosciences retains rights for all other fields. “We are […]
Reinach, Switzerland 9/27/13—Endress+Hauser, a supplier of industrial measurement and automation equipment, has announced that, following its purchase of 47% of the shares of publicly held German analytical instrument firm Analytik Jena, it is preparing an offer to shareholders to acquire the remaining shares. The company plans to offer €13.75 ($18.57 = €0.74 = $1) per […]
Santa Clara, CA 9/19/13; Santa Clara, 9/19/13—Agilent Technologies has announced plans to spin off its Electronic Measurement division as a separately traded public company. The remaining business, consisting of the company’s Life Sciences, Chemical Analysis and Diagnostics segments, will retain the Agilent name and continue under President and CEO William Sullivan. Those businesses are estimated […]
The second of IBO’s biannual new laboratory roundup focuses on new academic, pharmaceutical, and oil and gas labs. In addition, the table on page 3 highlights plans for new labs for the automotive and food industries, as well as for cancer research. Seven life science teaching labs have recently been announced. Johns Hopkins’ Undergraduate Teaching […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
